Bausch Health Companies (BHC) Enterprise Value (2009 - 2026)

Bausch Health Companies has disclosed Enterprise Value across 18 years of filings, most recently posting -$335.0 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$335.0 million, down 56.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$335.0 million (down 56.54% YoY), and the FY2025 annual result was -$394.0 million, down 61.48% from the prior year.
• Enterprise Value came in at -$335.0 million for Q1 2026 at Bausch Health Companies, up from -$394.0 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $461.0 million in Q3 2022 to a low of -$2.4 billion in Q1 2022.
• The 5-year median for Enterprise Value is -$22.0 million (2023), against an average of -$196.4 million.
• Across the five-year window, Enterprise Value jumped 170.78% in 2022 and sank 1009.09% in 2024, its largest moves.
• Bausch Health Companies' Enterprise Value stood at $361.0 million in 2022, then plunged by 106.09% to -$22.0 million in 2023, then tumbled by 1009.09% to -$244.0 million in 2024, then sank by 61.48% to -$394.0 million in 2025, then climbed by 14.97% to -$335.0 million in 2026.
• The last three Enterprise Value figures came in at -$335.0 million (Q1 2026), -$394.0 million (Q4 2025), and -$419.0 million (Q3 2025), per Business Quant data.